We found that increasing serum irisin was significantly associated with reduced risks of MetS and raised FPG even after adjustment for potential confounding factors, while the associations of serum irisin with rasied blood pressure and raised triglyceride were not statistically significant. The gene discussed is FNDC5; the disease is metabolic syndrome.